Completed

2

20

RoW

Zanubrutinib

Peking University People's Hospital

Immune Thrombocytopenia, Bruton Tyrosine Kinase

10/22

10/22

Active, not recruiting

2

532

Europe, Japan, US, RoW

Enpatoran low dose, M5049, Enpatoran medium dose, Enpatoran high dose, Placebo

EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany

Systemic Lupus Erythematosus

07/24

08/24

Completed

N/A

800

RoW

The Second Hospital of Lanzhou University

Atrial Fibrillation, Persistent, Blood Pressure

05/24

05/24

Active, not recruiting

N/A

100

RoW

Eltrombopag, Recombinant human thrombopoietin (rh-TPO)

Peking University People's Hospital

Corticosteroid-resistant or Relapsed ITP

08/22

12/22

Recruiting

N/A

444

RoW

Arrowga+rd Blue Advance Protection PICC Placement, Sham Comparator PICC placement

Teleflex

Peripherally Inserted Central Catheter

06/23

06/23

Recruiting

N/A

300

RoW

Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Hepatocellular Carcinoma

03/26

03/26

Recruiting

2

180

RoW

Adjuvant treatment for MRD positivity

Guangdong Association of Clinical Trials

MRD

10/25

10/30

Recruiting

N/A

2000

RoW

Surgeries

The First Affiliated Hospital of Guangzhou Medical University

NSCLC, Stage I, NSCLC, Stage II, NSCLC, Stage III

01/24

07/24

Active, not recruiting

4

354

RoW

PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter Regimen

Huashan Hospital

Multidrug Resistant Tuberculosis

05/23

11/23

Recruiting

4

364

RoW

Tobramycin Inhalant Product, Inhaled antibiotics, Ciprofloxacin 750 MG, Oral antibiotics, Oral ciprofloxacin placebo, Natural saline inhalation, Inhaled saline

Shanghai Pulmonary Hospital, Shanghai, China

Bronchiectasis Adult, Pseudomonas Aeruginosa Infection

05/25

12/25

Recruiting

2

30

RoW

HLX208

Shanghai Henlius Biotech

Advanced Melanoma

08/23

08/24

Recruiting

2

115

RoW

VC004

Jiangsu vcare pharmaceutical technology co., LTD

Locally Advanced Solid Tumor, Metastatic Solid Tumor

01/24

06/24

Active, not recruiting

1/2

99

RoW

Mannitol

Beijing Tiantan Hospital

Aneurysmal Subarachnoid Hemorrhage

11/23

01/24

Recruiting

1/2

42

RoW

T3011

Shanghai Pharmaceuticals Holding Co., Ltd

Advanced Melanoma

09/24

07/25

Recruiting

1/2

63

RoW

SPH4336, Cadonilimab

Shanghai Pharmaceuticals Holding Co., Ltd

Advanced Solid Tumors

05/25

12/25

Recruiting

1

156

RoW

JS004, a recombinant humanized, IgG4κ monoclonal antibody (mAb) specific to B- and T-lymphocyte attenuator (BTLA); Toripalimab Injection

Shanghai Junshi Bioscience Co., Ltd.

Melanoma, Renal Carcinoma, Urothelial Carcinoma

02/24

08/24

Active, not recruiting

N/A

89

RoW

Bedaquiline, BDQ, Pyrazinamide, PZA, Linezolid, LZD, Cycloserine, Cs, Clofazimine, CFZ

Huashan Hospital

Multidrug Resistant Tuberculosis

04/23

11/23

Recruiting

N/A

40

RoW

real rTMS, sham rTMS

Second Affiliated Hospital of Soochow University

Essential Tremor

10/26

12/26

Not yet recruiting

N/A

630

RoW

Beijing Friendship Hospital

Autoimmune Hepatitis

05/34

05/34

Recruiting

N/A

3000

Europe, US, RoW

Xingshun Qi

GastroIntestinal Bleeding

12/24

12/24

Recruiting

N/A

120

RoW

Treatment with Akkermansia muciniphila, Treatment with placebo

Yu Chen

Obesity Associated Disorder

12/24

12/24

Recruiting

N/A

300

RoW

Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Hepatocellular Carcinoma

03/26

03/26

Not yet recruiting

N/A

500

RoW

Huashan Hospital

Multidrug Resistant Tuberculosis

12/22

12/22

Recruiting

1/2

78

RoW

TQ05105 Tablets, TQB3617 Capsules

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Myelofibrosis

12/26

04/27

Recruiting

N/A

50000

RoW

No additional intervention will be administered.

Peking Union Medical College Hospital, Xuanwu Hospital, Beijing, Beijing Hospital, Tianjin First Central Hospital, Hebei Medical University Third Hospital, Dalian Hospital of Chinese Traditional and Western Medicine, The Second Affiliated Hospital of Harbin Medical University, Peking University Third Hospital, Beijing Shijingshan Hospital, The Second Medical Center of The General Hospital of the People's Liberation Army, Huamei hospital, University of Chinese Academy of Sciences, Second Affiliated Hospital, School of Medicine, Zhejiang University, Shanghai 10th People's Hospital, Ruijin Hospital, The First People's Hospital of Changzhou, Affiliated Hospital of Nantong University, Nantong First People's Hospital, Shanghai Changzheng Hospital, Wuhan Union Hospital, China, Central South University, Guangdong Provincial People's Hospital, Nanfang Hospital of Southern Medical University, Lunjiao Hospital of Shunde Foshan, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou Second Hospital, Second Affiliated Hospital of Guangzhou Medical University, Shenzhen Second People's Hospital, The Seventh Affiliated Hospital of Sun Yat-sen University, Sichuan Provincial People's Hospital, West China Fourth Hospital, Sichuan Province Orthopedic Hospital, The Second Affiliated Hospital of Chongqing Medical University, Daping Hospital, Army Medical Center of PLA, Guizhou Provincial Orthopedics Hospital, First Affiliated Hospital Xi'an Jiaotong University, Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, The First Affiliated Hospital of Zhengzhou University

Osteoporosis, Osteoporotic Fractures

12/24

12/24

Recruiting

N/A

300

RoW

Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Hepatocellular Carcinoma

03/26

03/26

Recruiting

2

120

RoW

HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched placebo tablets

Hansoh BioMedical R&D Company

Psoriasis

07/24

08/24

Not yet recruiting

N/A

60

RoW

mindfulness-based cognitive therapy (MBCT), Antipsoriatic treatment

First Affiliated Hospital Xi'an Jiaotong University

Psoriasis

01/22

01/22

Recruiting

3

970

RoW

Epirubicin plus Cyclophosphamide, EC, Taxanes, Taxanes plus Carboplatin

Shanghai Jiao Tong University School of Medicine

Breast Neoplasm

12/22

12/23

Recruiting

N/A

286

RoW

DCB of Lepu Medical(dimeter≥2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary small vessels, Restore DEB, RESTORE Paclitaxel releasing coronary balloon catheter, DCB of Lepu Medical(dimeter<2.00 mm), Coronary Drug Coated Balloon Catheter of Lepu Medical for coronary very small vessels

Lepu Medical Technology (Beijing) Co., Ltd.

Coronary Artery Disease

06/22

04/23

Recruiting

N/A

7000

RoW

coronary artery imaging (coronary CTA or coronary angiography)

Yong Zeng

Coronary Artery Disease, Artificial Heart Device User

08/24

12/24

Recruiting

N/A

300

RoW

Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Hepatocellular Carcinoma

03/26

03/26

Recruiting

N/A

300

RoW

Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Hepatocellular Carcinoma

03/26

03/26

Recruiting

1/2

80

RoW

mesenchymal stem cells, KY-2023-2-6-2, saline

Cell Energy Life Sciences Group Co. LTD, Beijing 302 Hospital

Lung Injury

05/26

05/26

Recruiting

N/A

300

RoW

Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Hepatocellular Carcinoma

03/26

03/26